Price data is not available
Burning Rock Biotech Ltd
BNRNASDAQ
Burning Rock Biotech (BNR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Burning Rock Biotech (BNR) last issued guidance on May 30, 2023 for fiscal year 2023. The company guided revenue in the range of $97.99M - $97.99M for the period.
Compared to prior guidance, Burning Rock Biotech maintained its revenue forecast from a prior range of $97.99M - $97.99M.
Burning Rock Biotech has issued 4 guidance updates between November 16, 2022 and May 30, 2023. During this period, the company raised its outlook 2 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-0.20 | $-0.20 | $-0.20 | $-0.20 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $19.9M | $15.6M | $18.1M | $18.5M |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 28, 2023 | $-3.10 | $-3.80 | 18.4 % |
| Q3 | Nov 15, 2022 | $-3.10 | $-3.20 | 3.12 % |
| Q2 | Aug 31, 2022 | $-3.70 | $-3.50 | -5.71 % |
| Q1 | May 31, 2022 | $-3.90 | $-3.60 | -8.33 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 28, 2023 | $20.62M | $16.10M | 28.1 % |
| Q3 | Nov 15, 2022 | $21.74M | $21.15M | 2.78 % |
| Q2 | Aug 31, 2022 | $19.53M | $22.15M | -11.8 % |
| Q1 | May 31, 2022 | $21.38M | $20.81M | 2.73 % |
